Catherine E. Owen

Insider Reports History

Entity
Individual
Location
1020 Stony Hill Road, Suite 300, Yardley, PA
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine E. Owen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AGIOS PHARMACEUTICALS, INC. Director Restricted stock units 2.12K $104K $48.84 Jun 20, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Director Common stock 1.98K $96.5K $48.84 Jun 13, 2024 Direct
ACADIA PHARMACEUTICALS INC Chief Executive Officer, Director Stock Option (Right to Buy) 353K Sep 23, 2024 Direct
OptiNose, Inc. Director Stock Option (Right to Buy) 75K Jun 6, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Director Stock options (right to buy) 11.8K Jun 20, 2024 Direct

Insider Reports Filed by Catherine E. Owen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACAD ACADIA PHARMACEUTICALS INC Sep 23, 2024 1 $0 4 Sep 25, 2024 Chief Executive Officer, Director
ACAD ACADIA PHARMACEUTICALS INC Sep 23, 2024 0 $0 3 Sep 25, 2024 Chief Executive Officer, Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 20, 2024 2 $0 4 Jun 24, 2024 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 13, 2024 2 $0 4 Jun 17, 2024 Director
OPTN OptiNose, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 13, 2023 2 $0 4 Jun 15, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 13, 2023 0 $0 3 Jun 15, 2023 Director
OPTN OptiNose, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
OPTN OptiNose, Inc. Jun 8, 2022 1 $0 4 Jun 9, 2022 Director
OPTN OptiNose, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director